14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.48 $1.48 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $1.48 $1.48
52 weeks $0.82 $2.87

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Aug 31, 2022 $2.75 $2.87 $2.72 $2.72 83 061
Aug 30, 2022 $2.99 $3.03 $2.72 $2.75 218 211
Aug 29, 2022 $3.10 $3.12 $2.96 $2.99 154 190
Aug 26, 2022 $3.19 $3.21 $3.13 $3.14 117 790
Aug 25, 2022 $3.20 $3.21 $3.15 $3.21 63 349
Aug 24, 2022 $3.10 $3.18 $3.09 $3.16 123 987
Aug 23, 2022 $3.07 $3.12 $3.04 $3.08 65 073
Aug 22, 2022 $3.07 $3.16 $3.05 $3.05 308 604
Aug 19, 2022 $3.28 $3.33 $3.06 $3.11 225 372
Aug 18, 2022 $3.65 $3.80 $3.32 $3.33 325 474
Aug 17, 2022 $3.65 $3.75 $3.60 $3.66 292 808
Aug 16, 2022 $3.78 $3.83 $3.68 $3.74 428 790
Aug 15, 2022 $3.84 $3.88 $3.74 $3.75 355 298
Aug 12, 2022 $3.62 $3.72 $3.58 $3.70 224 379
Aug 11, 2022 $3.55 $3.68 $3.54 $3.63 313 353
Aug 10, 2022 $3.42 $3.60 $3.32 $3.52 328 869
Aug 09, 2022 $3.36 $3.43 $3.30 $3.38 212 925
Aug 08, 2022 $3.29 $3.44 $3.27 $3.35 196 932
Aug 05, 2022 $3.23 $3.37 $3.21 $3.28 122 797
Aug 04, 2022 $3.23 $3.31 $3.20 $3.25 244 209
Aug 03, 2022 $3.15 $3.37 $3.15 $3.19 274 577
Aug 02, 2022 $2.98 $3.19 $2.98 $3.13 178 110
Aug 01, 2022 $3.18 $3.22 $2.99 $3.03 195 512
Jul 29, 2022 $3.13 $3.19 $3.02 $3.18 183 958
Jul 28, 2022 $3.12 $3.17 $3.00 $3.15 151 219

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use TCRR stock historical prices to predict future price movements?
Trend Analysis: Examine the TCRR stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the TCRR stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT